MaRS and the University of Toronto announced they will be leasing 24,000 square feet of office space in the Waterfront Innovation Centre, a development on the inner harbour near Sugar Beach, when it opens in 2021.

The third annual Medicine by Design Symposium will bring together principal investigators and trainees from across the University of Toronto and affiliated hospitals, along with members of Medicine by Design's Scientific Advisory Board, to share research and ignite new collaborations.

The report entitled “The Innovation and Competitiveness Imperative: Seizing Opportunities for Growth”, contains recommendations from six sectors with high growth potential, including the health and biosciences sector. The report outlined the roadmap to doubling the size of the health and biosciences sector and becoming a top-three global hub.

Elucid Labs was named the winner of Elevate Tech Fest's ElevateR Pitch Competition, and pitched live before Al Gore's keynote address.

VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, announced that the independent Data and Safety Monitoring Board (DSMB) completed its second safety assessment of the ongoing Phase 1/2a clinical study of VBI-1901 in recurrent GBM.

ManagingLife’s (OBIO Pre-CAAP 2018 Company) app that helps people explain their pain patterns to their healthcare providers will now be offered through Sun Life Financial's digital health community.

ProteinQure will begin a joint research project with Fujitsu Laboratories in order to accelerate the discovery of mid-size protein therapeutics.

The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest and in partnership with National Bank, announced the launch of a new Mentorship, Capital and Continuation Program (MC2). MC2 will accelerate market-ready healthcare innovations for the aging population from bench to bedside more quickly and efficiently.

Awake Labs (OBIO Pre-CAAP 2018 Company), Holland Bloorview Kids Rehabilitation Hospital – with support from the Ontario Brain Institute (OBI) – have come together to bring a new technology to the autism community via a pilot with a local community partner.

Trexo Robotics (OBIO Pre-CAAP 2018 Company) was featured as one of The 10 Most Innovative Medical Devices Companies in 2018 by Insights Care, a publication that covers important issues and trends shaping the future of the healthcare industry. 

Charles Plant at the Impact Centre, in partnership with Openview and Communitech, examined thousands of software companies to uncover their secrets to driving growth. The published report sets out important growth metrics, particularly relevant for companies selling Software as a Service (SaaS).

Employee health provider HumanaCare announced that it has provided access to therapy for 1.3 million Canadians since acquiring TranQool (OBIO Pre-CAAP 2016 Company) in May 2018.

As part of the 2018 MedTech Conference, the MedTech Canada Innovation Breakfast Seminar will cover the topic of “Connected Medical Devices - New Paradigms of Care” and will feature US and Canadian experts.

McMaster’s new Fraunhofer Project Centre for Biomedical Engineering and Advanced Manufacturing (FPC-BEAM) will be hosting a workshop titled “Developing Clinical Point-of-Care (POC) Diagnostics for Improving Healthcare Outcomes” at the McMaster Innovation Park on September 26th and 27th.

Jessica Ching (Eve Kit, OBIO CAAP 2013 Company) and Noureddin Chahrour (AdrenalEase, OBIO Pre-CAAP 2018 Company) have been nominated in the Toronto Region category for the 2018 Manning Innovation Awards. The winners will be announced later this fall, and will be celebrated at the 2018 Manning Innovation Awards Dinner on October 24, 2018.

Elucid Labs was named a finalist for the 2018 ElevatR Pitch Competition run by Elevate TechFest, and will compete for over $1M in potential funding.

Antibe Therapeutics announced that it has entered into an exclusive licensing agreement with Kwang Dong Pharmaceutical for the development and commercialization of Antibe’s lead drug, ATB-346, in South Korea.

Interesting monthly science review from Bloom Burton & Co highlights scientific achievements from across the country.

Iris Technologies' Non-LCD Computer Screen was used in a concussion study published in the Journal of Neurotrauma.